Hydrogen sulfide (HS) is a newly recognized gasotransmitter. Studies have demonstrated that the production of endogenous HS and the exogenous administration of HS can regulate many physiological and/or pathological processes. Therefore, HS releasing agents (also known as HS donors) are important research tools in advancing our understanding of the biology and clinical potential of HS. Among currently available donors, GYY4137 is probably the most well-known and has been used in many studies in the past 10 years. Recently, a number of GYY4137 derivatives (e.g., phosphonothioate-based compounds) have been developed as HS donors. In this review, we summarize the development and application of these donors, which include Lawesson's reagent, substituted phosphorodithioates, cyclic phosphorane analogs, and pH-controlled phosphonamidothioates (JK donors). These donors have advantages such as good water-solubility, slow and controllable HS release capability, and a variety of reported biological activities. However, it should be noted that the detailed HS release profiles and byproducts under real biological systems are still unclear for many of these donors. Only after we figure out these unknowns we will see better applications of these donors in HS research and therapy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502280 | PMC |
http://dx.doi.org/10.3389/fphar.2017.00457 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!